Product Information

Contents: Affinity Purified anti-human VEGF (121, 165, and 189 isoforms)
Catalog Number: 14-6782
Formulation: 200 µg/ml mouse monoclonal IgG1 in PBS containing 0.1 % sodium azide and 0.2% gelatin.
Storage Conditions: Store at 4°C.
DO NOT FREEZE.
Clone: VG-1
Isotype: Mouse IgG1

Available Formats of This Product
Cat. No.	Format	Excite (nm)	Emit (nm)	Reported Applications

Custom Product Requests
Need a custom product? Download the Custom Product Request Form and submit completed form to customs@ebioscience.com.

Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq.

Description

The monoclonal antibody reacts with human VEGF. The vascular endothelial growth factor (VEGF) family currently includes VEGF (VEGF-A), VEGF-B, VEGF-C, VEGF-D, VEGF-E, and PIGF (1). VEGF and its receptor system have been shown to be the fundamental regulators in the cell signaling of angiogenesis (2). Most tumors have the absolute requirement of angiogenesis and VEGF has been described as the most potent angiogenic cytokine linked to this process (3&4). To date 5 different isoforms of VEGF have been described, VEGF 121, VEGF 145, VEGF 165, VEGF 165b, and VEGF 189(4&5). These isoforms are generated as the result of alternative splicing from a single VEGF gene. These various isoforms have been shown to bind to two tyrosine-kinase receptors flt-1 (VEGFR-1) and flk-1/KDR (VEGFR-2), which have been found to be expressed almost exclusively on endothelial cells (5).

Applications Reported

For research use only, not for diagnostic or therapeutic use. Purified anti-human VEGF (121, 165, and 189 isoforms) has been reported for use in immunoblotting (WB), immunohistochemical staining (starting at 1:50), and ELISA.

Applications Tested

Purified anti-human VEGF (121, 165, and 189 isoforms) has been tested by immunoblotting (WB)(1:200 starting dilution). It is recommended that this antibody be titrated for optimal performance in the assay of interest.

References

1. Matsumoto T, Claesson-Welsh L. 2001. VEGF receptor signal transduction. Sci STKE 112:RE21.
2. Shibuya M. 2001. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct 26(1):25-35.
3. Hasan J, Jasyson GC. 2001. VEGF antagonists. Expert Opin Biol Ther 1(4):703-18.
4. Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, Peat D, Gillatt D, Harper SJ. 2002. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 62(14):4123-31.
5. Neufel G, Cohen T, Gengrinovitch S, Poltorak Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB 13(1):9-22.

Related Products

Cat. 00-0000  eBioscience 10X ELISA Coating Buffer
Cat. 44-2404  Nunc MaxiSorp™ flat-bottom 96 well plate
Cat. 18-4100  Avidin Horse Radish Peroxidase (AV-HRP)
Cat. 00-4202  eBioscience ELISA Diluent Solution, 5X
Cat. 18-8816  Rabbit TrueBlot™: Horseradish Peroxidase (HRP) anti-rabbit IgG